397 related articles for article (PubMed ID: 33128835)
1. Regulatory feedback cycle of the insulin-degrading enzyme and the amyloid precursor protein intracellular domain: Implications for Alzheimer's disease.
Lauer AA; Mett J; Janitschke D; Thiel A; Stahlmann CP; Bachmann CM; Ritzmann F; Schrul B; Müller UC; Stein R; Riemenschneider M; Grimm HS; Hartmann T; Grimm MOW
Aging Cell; 2020 Nov; 19(11):e13264. PubMed ID: 33128835
[TBL] [Abstract][Full Text] [Related]
2. New Insights into Epigenetic and Pharmacological Regulation of Amyloid-Degrading Enzymes.
Nalivaeva NN; Belyaev ND; Turner AJ
Neurochem Res; 2016 Mar; 41(3):620-30. PubMed ID: 26376806
[TBL] [Abstract][Full Text] [Related]
3. beta-Amyloid precursor protein metabolism: focus on the functions and degradation of its intracellular domain.
Buoso E; Lanni C; Schettini G; Govoni S; Racchi M
Pharmacol Res; 2010 Oct; 62(4):308-17. PubMed ID: 20561999
[TBL] [Abstract][Full Text] [Related]
4. Insulin-degrading enzyme rapidly removes the beta-amyloid precursor protein intracellular domain (AICD).
Edbauer D; Willem M; Lammich S; Steiner H; Haass C
J Biol Chem; 2002 Apr; 277(16):13389-93. PubMed ID: 11809755
[TBL] [Abstract][Full Text] [Related]
5. APP intracellular domain derived from amyloidogenic β- and γ-secretase cleavage regulates neprilysin expression.
Grimm MO; Mett J; Stahlmann CP; Grösgen S; Haupenthal VJ; Blümel T; Hundsdörfer B; Zimmer VC; Mylonas NT; Tanila H; Müller U; Grimm HS; Hartmann T
Front Aging Neurosci; 2015; 7():77. PubMed ID: 26074811
[TBL] [Abstract][Full Text] [Related]
6. GEPT extract reduces Abeta deposition by regulating the balance between production and degradation of Abeta in APPV717I transgenic mice.
Tian J; Shi J; Zhang L; Yin J; Hu Q; Xu Y; Sheng S; Wang P; Ren Y; Wang R; Wang Y
Curr Alzheimer Res; 2009 Apr; 6(2):118-31. PubMed ID: 19355846
[TBL] [Abstract][Full Text] [Related]
7. Amyloid precursor protein (APP) mediated regulation of ganglioside homeostasis linking Alzheimer's disease pathology with ganglioside metabolism.
Grimm MO; Zinser EG; Grösgen S; Hundsdörfer B; Rothhaar TL; Burg VK; Kaestner L; Bayer TA; Lipp P; Müller U; Grimm HS; Hartmann T
PLoS One; 2012; 7(3):e34095. PubMed ID: 22470521
[TBL] [Abstract][Full Text] [Related]
8. Notch signaling proteins HES-1 and Hey-1 bind to insulin degrading enzyme (IDE) proximal promoter and repress its transcription and activity: implications for cellular Aβ metabolism.
Leal MC; Surace EI; Holgado MP; Ferrari CC; Tarelli R; Pitossi F; Wisniewski T; Castaño EM; Morelli L
Biochim Biophys Acta; 2012 Feb; 1823(2):227-35. PubMed ID: 22036964
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of PGC-1α expression by Alzheimer's disease-associated pathway: presenilin 1/amyloid precursor protein (APP)/intracellular domain of APP.
Robinson A; Grösgen S; Mett J; Zimmer VC; Haupenthal VJ; Hundsdörfer B; Stahlmann CP; Slobodskoy Y; Müller UC; Hartmann T; Stein R; Grimm MO
Aging Cell; 2014 Apr; 13(2):263-72. PubMed ID: 24304563
[TBL] [Abstract][Full Text] [Related]
10. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo.
Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S
Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421
[TBL] [Abstract][Full Text] [Related]
11. The transcriptionally active amyloid precursor protein (APP) intracellular domain is preferentially produced from the 695 isoform of APP in a {beta}-secretase-dependent pathway.
Belyaev ND; Kellett KA; Beckett C; Makova NZ; Revett TJ; Nalivaeva NN; Hooper NM; Turner AJ
J Biol Chem; 2010 Dec; 285(53):41443-54. PubMed ID: 20961856
[TBL] [Abstract][Full Text] [Related]
12. Cerebrolysin decreases amyloid-beta production by regulating amyloid protein precursor maturation in a transgenic model of Alzheimer's disease.
Rockenstein E; Torrance M; Mante M; Adame A; Paulino A; Rose JB; Crews L; Moessler H; Masliah E
J Neurosci Res; 2006 May; 83(7):1252-61. PubMed ID: 16511867
[TBL] [Abstract][Full Text] [Related]
13. Insulysin cleaves the APP cytoplasmic fragment at multiple sites.
Venugopal C; Pappolla MA; Sambamurti K
Neurochem Res; 2007 Dec; 32(12):2225-34. PubMed ID: 17701350
[TBL] [Abstract][Full Text] [Related]
14. Effect of Global Brain Ischemia on Amyloid Precursor Protein Metabolism and Expression of Amyloid-Degrading Enzymes in Rat Cortex: Role in Pathogenesis of Alzheimer's Disease.
Babusikova E; Dobrota D; Turner AJ; Nalivaeva NN
Biochemistry (Mosc); 2021 Jun; 86(6):680-692. PubMed ID: 34225591
[TBL] [Abstract][Full Text] [Related]
15. Thymoquinone-rich fraction nanoemulsion (TQRFNE) decreases Aβ40 and Aβ42 levels by modulating APP processing, up-regulating IDE and LRP1, and down-regulating BACE1 and RAGE in response to high fat/cholesterol diet-induced rats.
Ismail N; Ismail M; Azmi NH; Bakar MFA; Yida Z; Abdullah MA; Basri H
Biomed Pharmacother; 2017 Nov; 95():780-788. PubMed ID: 28892789
[TBL] [Abstract][Full Text] [Related]
16. Increased expression of Abeta degrading enzyme IDE in the cortex of transgenic mice with Alzheimer's disease-like neuropathology.
Vepsäläinen S; Hiltunen M; Helisalmi S; Wang J; van Groen T; Tanila H; Soininen H
Neurosci Lett; 2008 Jun; 438(2):216-20. PubMed ID: 18455870
[TBL] [Abstract][Full Text] [Related]
17. BRI2 protein regulates β-amyloid degradation by increasing levels of secreted insulin-degrading enzyme (IDE).
Kilger E; Buehler A; Woelfing H; Kumar S; Kaeser SA; Nagarathinam A; Walter J; Jucker M; Coomaraswamy J
J Biol Chem; 2011 Oct; 286(43):37446-57. PubMed ID: 21873424
[TBL] [Abstract][Full Text] [Related]
18. NFkappaB-dependent control of BACE1 promoter transactivation by Abeta42.
Buggia-Prevot V; Sevalle J; Rossner S; Checler F
J Biol Chem; 2008 Apr; 283(15):10037-47. PubMed ID: 18263584
[TBL] [Abstract][Full Text] [Related]
19. Copper(I) and copper(II) inhibit Aβ peptides proteolysis by insulin-degrading enzyme differently: implications for metallostasis alteration in Alzheimer's disease.
Grasso G; Pietropaolo A; Spoto G; Pappalardo G; Tundo GR; Ciaccio C; Coletta M; Rizzarelli E
Chemistry; 2011 Feb; 17(9):2752-62. PubMed ID: 21274957
[TBL] [Abstract][Full Text] [Related]
20. Eicosapentaenoic acid and docosahexaenoic acid increase the degradation of amyloid-β by affecting insulin-degrading enzyme.
Grimm MO; Mett J; Stahlmann CP; Haupenthal VJ; Blümel T; Stötzel H; Grimm HS; Hartmann T
Biochem Cell Biol; 2016 Dec; 94(6):534-542. PubMed ID: 27813426
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
